New York 2025 Session Status: Introduced

A11655 — Establishes a rare kidney disease screening pilot program

Last action — In Assembly Committee

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Assembly
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Assembly. Introduced July 29, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

Creates a pilot program for screening rare kidney disease in at-risk populations.

This bill establishes a pilot program to screen for rare kidney disease in certain regions, aiming for early diagnosis and improved patient care. It will target at-risk groups and assess the program's effectiveness and scalability.

What this means for you
  • Workers: {}
  • Families: Families of at-risk individuals could benefit from earlier diagnosis and improved access to treatments.
  • Healthcare: This means healthcare providers may have new guidelines and tools to better identify and treat rare kidney disease.

Summary

Establishes a rare kidney disease screening pilot program within the department of health to operate in at least two counties or regions in the state, targeting at-risk populations, to improve early diagnosis of RKD, connect patients with treatments and care, and evaluate the effectiveness and scalability of state-based RKD screening initiatives.

Bill Text

Action History

  1. REFERRED TO HEALTH

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 218 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (218)

218 members have not signed on to this bill.

Show all 218 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does A11655 do?
Establishes a rare kidney disease screening pilot program within the department of health to operate in at least two counties or regions in the state, targeting at-risk populations, to improve early diagnosis of RKD, connect patients with treatments and care, and evaluate the effectiveness and scalability of state-based RKD screening initiatives.
Who sponsors A11655?
A11655 is sponsored by Yudelka Tapia.
What is the current status of A11655?
This bill has been introduced in the Assembly. Introduced July 29, 2026. It must pass committee before a floor vote.
Where can I track A11655?
Track A11655 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on A11655

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of A11655

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →